Used in research as a derivative of camptothecin, this compound functions as a topoisomerase I inhibitor, making it valuable in anticancer drug development. It is studied for its ability to interfere with DNA replication in tumor cells, leading to cell death. Its structure allows for improved solubility and stability compared to parent compounds, which enhances its potential for use in chemotherapy formulations. It has shown activity against various cancer cell lines, particularly in lung, colon, and ovarian cancers. Researchers also explore its use in targeted delivery systems, such as antibody-drug conjugates or nanoparticle-based therapies, to increase specificity and reduce side effects.